Specifications Table {#s0005}
====================

TableSubject area*Biology*More specific subject area*Dermatology, Immunology, and Genetics*Type of data*Tables*How data was acquired*The reviewing of the literature was made by using the Pubmed, and the HLA typing by using PCR-SSOP method*Data format*Analyzed*Experimental factors*DNA blood samples from pemphigus patients and controls*Experimental features*HLA class I and II typing was performed using commercial kits (One Lambda Inc., Canoga Park, CA)*Data source location*Northeastern region of the state of São Paulo, Southeastern Brazil*Data accessibility*Data is with this article*

Value of the data {#s0010}
=================

•The literature review regarding *HLA* class I/II data on pemphigus is shown in tables comparing different studied Brazilian populations.•The northeastern region of the state of São Paulo, Southeastern Brazil, is prevalent for both clinical forms of pemphigus--pemphigus foliaceus and pemphigus vulgaris, enabling a comparative study.•*HLA* class I/II frequencies are detailed comparing pemphigus foliaceus and pemphigus vulgaris patients from the same endemic region.

1. Data {#s0015}
=======

[Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"} describe the *HLA* class I and II data related to susceptibility/resistance to pemphigus foliaceus and pemphigus vulgaris in reviewed Brazilian reports. [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"}, [Table 5](#t0025){ref-type="table"}, [Table 6](#t0030){ref-type="table"}, [Table 7](#t0035){ref-type="table"}, [Table 8](#t0040){ref-type="table"} show the *HLA* class I (-*A*, -*B*, -*C*) and class II (-*DRB1*, -*DQA1*, -*DQB1*) profile performed in pemphigus foliaceus and pemphigus vulgaris patients from Southeastern Brazil.

2. Experimental design, materials, and methods {#s0020}
==============================================

A summary of Brazilian data regarding associations between *HLA* and pemphigus was obtained in PubMed. A hundred and sixty-nine patients followed up at the University Hospital of the Ribeirão Preto Medical School of the University of São Paulo, Brazil, were evaluated. Eighty-six and 83 patients exhibited PF and PV, respectively. The control group consisted of 1592 healthy individuals living in the northeastern region of the state of São Paulo, Southeastern Brazil. *HLA* class I and II typing was performed at low/high resolution by using commercial kits, according to the manufacturer׳s protocol (One Lambda Inc., Canoga Park, CA). The allelic frequencies of the *HLA* class I and II genes were estimated by direct counting. Comparison of allele frequency among the groups was performed by using Fisher׳s exact test or the Chi-square test. Significant *P*-values were corrected by the number of alleles tested for each locus. The relative risk (RR) 95% was estimated. Statistical analysis was performed with SAS 9.3 (SAS Institute Inc, EUA) and Epi InfoTM 7.0 (CDC, USA) software. Values *P*≤0.05 were considered significant. All the participants provided an informed written consent to participate in this study. The local Ethics Committee (\#12248/2010) approved this study.

Transparency document. Supplementary material {#s0030}
=============================================
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Transparency data associated with this article can be found in the online version at [doi:10.1016/j.dib.2016.05.077](http://dx.doi.org/10.1016/j.dib.2016.05.077){#ir0005}.

###### 

Brazilian reports on pemphigus foliaceus associated alleles.

Table 1

  **References**                              **Brazilian population**                                  **Patients/Controls**   ***DRB1\****            P-value, RR or OR         ***DQA1\****   *P*-value, RR       ***DQB1\****   *P*-value, RR or OR
  ------------------------------------------- --------------------------------------------------------- ----------------------- ----------------------- ------------------------- -------------- ------------------- -------------- -------------------------
  **Susceptibility -- Pemphigus Foliaceus**                                                                                                                                                                                         
  PetzL-Erler et al. (1989) [@bib2]           North to Southwest of the state of Paraná                 48/74                   01                      Pc=3.3×10^−3^, RR=6.4                                                       
  04                                          *P*=3.3×10^−3^, RR=3.3                                                                                                                                                                
  Moraes et al. (1991) [@bib3]                State of São Paulo and Brasília city (Federal District)   38/50                   01:02                   Pc=0.002, RR=7.3                                                            
  Cerna et al. (1993) [@bib4]                 Xavante Indians -- Central Brazil                         10/74                   04:04                   Pc=0.03, RR=9.6                                                             
  Moraes et al. (1997) [@bib5]                Terena Indians -- state of Mato Grosso do Sul             20/66                   04:04                   Pc=0.022, OR=6.1                                             03:02          Pc=0.04, OR=5.2
  Pavoni et al. (2003) [@bib6]                State of Mato Grosso do Sul and Paraná                    128/402                 01                      *P*\<10^−6^, OR=7.4                                                         
  01:01                                       *P*=0.042, OR=1.83                                                                                                                                                                    
  01:02                                       *P*\<10^−6^, OR=10.36                                                                                                                                                                 
  01:03                                       *P*=0.025, OR=5.41                                                                                                                                                                    
  04                                          *P*\<10^−6^, OR=2.66                                                                                                                                                                  
  04:04                                       *P*=4×10^−6^, OR=4.58                                                                                                                                                                 
  04:06                                       *P*=5.2×10^−6^, OR=35.85                                                                                                                                                              
  04:10                                       *P*=0.046, OR=9.62                                                                                                                                                                    
  14:06                                       *P*=0.04, OR=4.04                                                                                                                                                                     
  16:01                                       *P*=0.017, OR=2.87                                                                                                                                                                    
  Brochado et al. (2016) [@bib1]              Northeastern region of the state of São Paulo             86/1592                 01:01                   Pc=0.0001, RR=2.18        01             Pc=0.02, RR=1.41    05:01          Pc=2.5×10^−10^, RR=2.95
  01:02                                       Pc=5.4e^−10^, RR=6.06                                     01:02                   Pc=3.6×10^−3^, RR=2.3                                                                               
                                                                                                        03                      Pc=0.01, RR=1.78                                                                                    
                                                                                                                                                                                                                                    
  **Protection -- Pemphigus Foliaceus**                                                                                                                                                                                             
  Petzl-Erler et al. (1989) [@bib2]           North/Southwest of the state of Paraná                    48/74                   07                      Pc=9×10^−3^, RR=0.06                                         02:01          *P*=8.1×10^−3^, RR=0.27
  Moraes et al. (1991) [@bib3]                State of São Paulo and Brasília city (Federal District)   38/50                                                                                                        02:01          *P*=0.006, RR=0.04
                                                                                                                                                                                  06:02          Pc=0.042, OR=0.15                  
  Pavoni et al. (2003) [@bib6]                States of Mato Grosso do Sul and Paraná                   128/402                 03:01                   *P*=8.7×10^−4^, OR=0.23                                                     
  07:01                                       *P*\<10^−6^, OR=0.09                                                                                                                                                                  
  08                                          *P*=1×10^−3^, OR=0.27                                                                                                                                                                 
  08:01                                       *P*=7.2×10^−3^, OR=0.07                                                                                                                                                               
  11                                          *P*\<10^−6^, OR=0.09                                                                                                                                                                  
  11:01                                       *P*\<10^−6^, OR=0.05                                                                                                                                                                  
  11:04                                       *P*=0.03, OR=0.15                                                                                                                                                                     
  14:02                                       *P*=0.018, OR=0.09                                                                                                                                                                    
  15                                          *P*=0.019, OR=0.51                                                                                                                                                                    
  Brochado et al. (2016) [@bib1]              Northeastern region of the state of São Paulo                                     11:01                   Pc=0.027, RR=0.07         02:01          Pc=0.03, RR=0.34    03:01          Pc=0.0002; RR=0.39
                                              13:01                                                     Pc=0.027, OR=0.20       05                      Pc=1.08×10^−5^, RR=0.28   06:03          Pc=0.023, RR=0.2                   

RR=Relative risk, OR=odds ratio, Pc=*P*-values were corrected by the number of alleles tested for each locus.

###### 

Brazilian reports on pemphigus vulgaris associated alleles.

Table 2

  **References**                             **Brazilian population**                        **Patients/Controls**     ***DRB1\****   *P*-value, OR or RR        ***DQA1\****   *P*-value, OR      ***DQB1\****   *P*-value, RR
  ------------------------------------------ ----------------------------------------------- ------------------------- -------------- -------------------------- -------------- ------------------ -------------- --------------------------
  **Susceptibility -- Pemphigus Vulgaris**                                                                                                                                                                        
  Weber et al. (2011) [@bib7]                Southeastern region of the state of São Paulo   36/162                    04:02          OR=44.6                                                                     
  08:04                                      OR=18.6                                                                                                                                                              
  14                                         OR=4.8                                                                                                                                                               
  Brochado et al. (2016) [@bib1]             Northeastern region of the state of São Paulo   82/1592                   04:02          Pc=5.4×10^−10^, RR=12.54   03             Pc=0.01, OR=2.04   03:02          Pc=2.5×10^−10^, RR= 2.95
                                             08:04                                           Pc=5.4×10^−5^, RR=6       03:01          Pc=3.6×10^−4^, OR=4        05:03          Pc=0.02, OR=2.74                  
                                             14:01                                           Pc=5.4×10^−10^, RR=7                                                                                                 
                                             14:04                                           Pc=5.4×10^−4^, RR=16.64                                                                                              
                                                                                                                                                                                                                  
  **Protection -- Pemphigus Vulgaris**                                                                                                                                                                            
  Brochado et al. (2016) [@bib1]             Northeastern region of the state of São Paulo   82/1592                   07:01          Pc=0.027, RR=0.28                                            06:02          Pc=0.0075, RR=0.19

RR=Relative risk, OR=odds ratio, Pc=*P*-values were corrected by the number of alleles tested for each locus.

###### 

Allelic *HLA-A* frequencies among Brazilian pemphigus foliaceus and pemphigus vulgaris patients as compared to controls.

Table 3

  ***HLA-A\****   **Controls (*n*=1592)**   **Pemphigus foliaceus (*****n*****=83)**       **Pemphigus vulgaris (*****n*****=83)**
  --------------- ------------------------- ---------------------------------------------- ---------------------------------------------
  **01**          291 (9.14)                12 (7.23)                                      21 (12.65)
  **02**          1028 (32.29)              31 (18.67)[a](#tbl3fna){ref-type="table-fn"}   38 (22.89)
  **03**          277 (8.70)                18 (10.84)                                     9 (5.42)
  **04**          1 (0.03)                  0                                              0
  **06**          2 (0.06)                  0                                              0
  **11**          126 (3.96)                16 (9.64)[b](#tbl3fnb){ref-type="table-fn"}    11 (6.63)
  **23**          127 (3.99)                8 (4.82)                                       4 (2.41)
  **24**          324 (10.18)               16 (9.64)                                      18 (10.84)
  **25**          38 (1.19)                 2 (1.20)                                       4 (2.41)
  **26**          86 (2.70)                 5 (3.01)                                       13 (7.83)[c](#tbl3fnc){ref-type="table-fn"}
  **29**          114 (3.58)                4 (2.41)                                       2 (1.20)
  **30**          163 (5.12)                14 (8.43)                                      11 (6.63)
  **31**          149 (4.68)                6 (3.61)                                       4 (2.41)
  **32**          95 (2.98)                 3 (1.81)                                       5 (3.01)
  **33**          73 (2.29)                 11 (6.63)[d](#tbl3fnd){ref-type="table-fn"}    6 (3.61)
  **34**          18 (0.57)                 3 (1.81)                                       1 (0.60)
  **36**          13 (0.41)                 1 (0.60)                                       1 (0.60)
  **66**          17 (0.53)                 3 (1.81)                                       2 (1.20)
  **68**          205 (6.44)                8 (4.82)                                       13 (7.83)
  **69**          1 (0.03)                  0                                              0
  **74**          34 (1.07)                 5 (3.01)                                       1 (0.60)
  **80**          2 (0.06)                  0                                              2 (1.20)

RR=Relative Risk, CI=confidence interval.

*P*=2.10^−4^, RR=0.57, 95% CI=0.42--0.80.

*P*=0.04, RR=2.43, 95% CI=1.5--4.0.

*P*=0.02, RR=2.89, 95% CI=1.65--5.08.

*P*=0.04, RR=2.89, 95% CI=1.56--5.34.

###### 

Allelic *HLA-B\** frequencies among Brazilian pemphigus foliaceus and pemphigus vulgaris patients as compared to controls.

Table 4

  ***HLA-B\****   **Controls (*****n*****=1592)**   **Pemphigus foliaceus (*****n*****=83)**       **Pemphigus vulgaris (*****n*****=82)**
  --------------- --------------------------------- ---------------------------------------------- ---------------------------------------------
  **07**          229 (7.19)                        13 (7.83)                                      5 (3.05)
  **08**          111 (3.49)                        8 (4.82)                                       2 (1.22)
  **13**          35 (1.10)                         3 (1.81)                                       4 (2.44)
  **14**          161 (5.06)                        23 (13.86)[a](#tbl4fna){ref-type="table-fn"}   4 (2.44)
  **15**          379 (11.90)                       12 (7.23)                                      5 (3.05)[b](#tbl4fnb){ref-type="table-fn"}
  **18**          185 (5.81)                        3 (1.81)                                       5 (3.05)
  **27**          45 (1.41)                         3 (1.81)                                       4 (2.44)
  **35**          444 (13.94)                       19 (11.45)                                     26 (15.85)
  **37**          25 (0.79)                         3 (1.81)                                       2 (1.22)
  **38**          60 (1.88)                         2 (1.20)                                       12 (7.32)[c](#tbl4fnc){ref-type="table-fn"}
  **39**          113 (3.55)                        11 (6.63)                                      9 (5.49)
  **40**          124 (3.89)                        10 (6.02)                                      8 (4.88)
  **41**          31 (0.97)                         1 (0.60)                                       1 (0.61)
  **42**          33 (1.04)                         2 (1.20)                                       3 (1.83)
  **44**          333 (10.46)                       14 (8.43)                                      23 (14.02)
  **45**          45 (1.41)                         4 (2.41)                                       3 (1.83)
  **47**          5 (0.16)                          0                                              0
  **48**          21 (0.66)                         3 (1.81)                                       0
  **49**          68 (2.14)                         1 (0.60)                                       4 (2.44)
  **50**          75 (2.36)                         4 (2.41)                                       4 (2.44)
  **51**          330 (10.36)                       8 (4.82)                                       13 (7.93)
  **52**          49 (1.54)                         3 (1.81)                                       2 (1.22)
  **53**          55 (1.73)                         3 (1.81)                                       8 (4.88)
  **55**          33 (1.04)                         2 (1.20)                                       4 (2.44)
  **56**          4 (0.13)                          1 (0.60)                                       0
  **57**          92 (2.89)                         6 (3.61)                                       10 (6.10)
  **58**          86 (2.70)                         4 (2.41)                                       1 (0.61)
  **73**          4 (0.13)                          0                                              1 (0.61)
  **81**          8 (0.25)                          0                                              1 (0.61)
  **82**          1 (0.03)                          0                                              0

RR=Relative Risk, CI=confidence interval.

*P*=6×10^−4^, RR=2.74, 95% CI=1.82--4.12.

*P*=0.003, RR=0.26, 95% CI=0.10--0.61.

*P*=0.003, RR=3.88, 95% CI=2.13--7.07.

###### 

Allelic *HLA-C* frequencies among Brazilian pemphigus foliaceus and pemphigus vulgaris patients as compared to controls.

Table 5

  ***HLA-C\****   **Controls (*****n*****=1305)**   **Pemphigus foliaceus (*****n*****=83)**   **Pemphigus vulgaris (*****n*****=82)**
  --------------- --------------------------------- ------------------------------------------ ----------------------------------------------
  **01**          55 (2.11)                         3 (1.81)                                   5 (3.05)
  **02**          176 (6.74)                        15 (9.04)                                  10 (6.10)
  **03**          278 (10.65)                       14 (8.43)                                  11 (6.71)
  **04**          475 (18.20)                       27 (16.27)                                 32 (19.51)
  **05**          144 (5.52)                        8 (4.82)                                   13 (7.93)
  **06**          212 (8.12)                        14 (8.43)                                  14 (8.54)
  **07**          578 (22.15)                       33 (19.88)                                 24 (14.63)
  **08**          135 (5.17)                        17 (10.24)                                 5 (3.05)
  **12**          155 (5.94)                        10 (6.02)                                  21 (12.80)[a](#tbl5fna){ref-type="table-fn"}
  **14**          79 (3.03)                         0                                          4 (2.44)
  **15**          111 (4.25)                        13 (7.83)                                  11 (6.71)
  **16**          144 (5.52)                        7 (4.22)                                   10 (6.10)
  **17**          52 (1.99)                         3 (1.81)                                   4 (2.44)
  **18**          16 (0.61)                         2 (1.20)                                   0

RR=Relative Risk, CI=confidence interval

*P*=0.01, RR=2.16, 95% CI=1.40--3.30.

###### 

Allelic *HLA-DRB1* frequencies among Brazilian pemphigus foliaceus and pemphigus vulgaris patients as compared to controls.

Table 6

  ***HLA-DRB1⁎***   **Controls (*n*=1592)**   **Pemphigus foliaceus (*****n*****=86)**      **Pemphigus vulgaris (*****n*****=82)**
  ----------------- ------------------------- --------------------------------------------- ---------------------------------------------
  **01:01**         150 (4.7)                 23 (13.4)[a](#tbl6fna){ref-type="table-fn"}   6 (3.7)
  **01:02**         113 (3.6)                 37 (21.5)[b](#tbl6fnb){ref-type="table-fn"}   3 (1.8)
  **01:03**         22 (0.7)                  1 (0.6)                                       0
  **03:01**         247 (7.8)                 10 (5.8)                                      4 (2.4)
  **03:02**         25 (0.8)                  3 (1.7)                                       2 (1.2)
  **04**            0                         2 (1.2)                                       0
  **04:01**         79 (2.5)                  3 (1.7)                                       2 (1.2)
  **04:02**         65 (2.0)                  4 (2.3)                                       42 (25.6)[c](#tbl6fnc){ref-type="table-fn"}
  **04:03**         38 (1.2)                  2 (1.2)                                       4 (2.4)
  **04:04**         88 (2.8)                  10 (5.8)                                      5 (3.1)
  **04:05**         63 (2.0)                  4 (2.3)                                       1 (0.6)
  **04:06**         8 (0.3)                   1 (0.6)                                       0
  **04:07**         27 (0.9)                  1 (0.6)                                       0
  **04:08**         21 (0.7)                  2 (1.2)                                       0
  **04:10**         2 (0.1)                   0                                             0
  **04:11**         54 (1.7)                  7 (4.1)                                       2 (1.2)
  **07:01**         342 (10.7)                6 (3.5)                                       5 (3.1)[d](#tbl6fnd){ref-type="table-fn"}
  **08:01**         71 (2.2)                  0                                             2 (1.2)
  **08:02**         34 (1.1)                  3 (1.7)                                       1 (0.6)
  **08:03**         10 (0.3)                  0                                             0
  **08:04**         42 (1.3)                  2 (1.2)                                       13 (7.9)[e](#tbl6fne){ref-type="table-fn"}
  **08:07**         25 (0.8)                  1 (0.6)                                       0
  **09:01**         41 (1.3)                  4 (2.3)                                       0
  **10:01**         43 (1.4)                  1 (0.6)                                       1 (0.6)
  **11**            0                         0                                             1 (0.6)
  **11:01**         258 (8.1)                 1 (0.6)[f](#tbl6fnf){ref-type="table-fn"}     9 (5.5)
  **11:02**         72 (2.3)                  1 (0.6)                                       5 (3.1)
  **11:03**         31 (1.0)                  0                                             0
  **11:04**         138 (4.3)                 1 (0.6)                                       4 (2.4)
  **11:06**         1 (0.03)                  0                                             0
  **11:13**         1 (0.03)                  0                                             0
  **11:18**         1 (0.03)                  0                                             0
  **12:01**         35 (1.1)                  3 (1.7)                                       1 (0.6)
  **12:02**         3 (0.1)                   0                                             0
  **13:01**         274 (8.6)                 3 (1.7)[g](#tbl6fng){ref-type="table-fn"}     4 (2.4)
  **13:02**         158 (5.0)                 2 (1.2)                                       3 (1.8)
  **13:03**         55 (1.7)                  0                                             2 (1.2)
  **13:05**         2 (0.1)                   0                                             0
  **13:06**         1 (0.03)                  0                                             0
  **13:21**         1 (0.03)                  0                                             0
  **13:23**         1 (0.03)                  0                                             0
  **13:31**         1 (0.03)                  0                                             0
  **14:01**         70 (2.2)                  0                                             25 (15.2)[h](#tbl6fnh){ref-type="table-fn"}
  **14:02**         35 (1.1)                  1 (0.6)                                       3 (1.8)
  **14:04**         7 (0.2)                   2 (1.2)                                       6 (3.7)[i](#tbl6fni){ref-type="table-fn"}
  **14:06**         7 (0.2)                   1 (0.6)                                       0
  **14:09**         1 (0.03)                  0                                             0
  **15:01**         194 (6.1)                 12 (7.0)                                      2 (1.2)
  **15:02**         24 (0.8)                  0                                             2 (1.2)
  **15:03**         79 (2.5)                  5 (2.9)                                       0
  **15:04**         1 (0.03)                  0                                             0
  **15:11**         1 (0.03)                  0                                             0
  **16:01**         66 (2.1)                  10 (5.8)                                      2 (1.2)
  **16:02**         56 (1.8)                  3 (1.7)                                       2 (1.2)

RR=relative risk, CI=confidence interval.

*P*=1×10^−4^, RR=2.83, 95% CI=1.88--4.28.

*P*=5×10^−10^, RR=6.06, 95% CI=4.32--8.49.

*P*=5.4×10^−10^, RR=12.54, 95% CI=8.79--17.88.

*P*=0.027, RR=0.28, 95% CI=0.12--0.67.

*P*=5.4×10^−5^, RR=6.0, 95% CI=3.29--10.97.

*P*=0.027, RR=0.07, 95% CI=0.01--0.50.

*P*=0.027, RR=0.20, 95% CI=0.06--0.62.

*P*=5.4×10^−10^, RR=7.21, 95% CI=4.72--10.99.

*P*=5.4×10^−4^, RR=16.64, 95% CI=5.65--48.95.

###### 

Allelic *HLA-DQA1* frequencies among Brazilian pemphigus foliaceus and pemphigus vulgaris patients as compared to controls.

Table 7

  ***HLA-DQA1⁎***   **Controls (*****n*****=1312)**   **Pemphigus foliaceus (*****n*****=86)**      **Pemphigus vulgaris (*****n*****=82)**
  ----------------- --------------------------------- --------------------------------------------- ---------------------------------------------
  **01**            760 (29.0)                        70 (40.7)[a](#tbl7fna){ref-type="table-fn"}   47 (28.7)
  **01:02**         155 (5.9)                         24 (14.0)[b](#tbl7fnb){ref-type="table-fn"}   8 (4.9)
  **01:03**         130 (5.0)                         3 (1.7)                                       4 (2.4)
  **01:06**         3 (0.11)                          0                                             0
  **01:07**         4 (0.15)                          2 (1.2)                                       0
  **01:09**         1 (0.04)                          0                                             0
  **02:01**         267 (10.2)                        6 (3.5)[c](#tbl7fnc){ref-type="table-fn"}     6 (3.7)
  **03**            318 (12.1)                        37 (21.5)[d](#tbl7fnd){ref-type="table-fn"}   36 (22.0)[e](#tbl7fne){ref-type="table-fn"}
  **03:01**         88 (3.4)                          5 (2.9)                                       20 (12.2)[f](#tbl7fnf){ref-type="table-fn"}
  **04**            1 (0.04)                          0                                             0
  **04:01**         146 (5.6)                         7 (4.1)                                       10 (6.1)
  **04:03**         2 (0.1)                           0                                             0
  **04:04**         2 (0.1)                           0                                             0
  **05**            499 (19.0)                        9 (5.2)[g](#tbl7fng){ref-type="table-fn"}     27 (16.5)
  **05:01**         201 (7.7)                         9 (5.2)                                       5 (3.1)
  **05:02**         2 (0.1)                           0                                             0
  **05:10**         33 (1.3)                          0                                             1 (0.6)
  **06:01**         12 (0.5)                          0                                             0

RR=relative risk, CI=confidence interval.

*P*=0.02, RR=1.41, 95% CI=1.16--1.69.

*P*=3.6×10^−3^, RR=2.36, 95% CI=1.58--3.52.

*P*=0.03, RR=0.34, 95% CI=0.15--0.75.

*P*=0.01, RR=1.78, 95% CI=1.31--2.40.

*P*=0.01, RR=1.81, 95% CI=1.33--2.46.

*P*=4×10^−4^, RR=3.64, 95% CI=2.29--5.75.

*P*=1.08×10^−5^, RR=0.28, 95% CI=0.14--0.52.

###### 

Allelic *HLA-DQB1* frequencies among Brazilian pemphigus foliaceus and pemphigus vulgaris patients as compared to controls.

Table 8

  ***HLA-DQB1\****   **Controls (*n*=1411)**   **Pemphigus foliaceus (*n*=86)**               **Pemphigus vulgaris (*n*=82)**
  ------------------ ------------------------- ---------------------------------------------- ----------------------------------------------
  **02:01**          233 (8.26)                9 (5.23)                                       4 (2.44)
  **02:02**          260 (9.21)                6 (3.49)                                       5 (3.05)
  **03**             2 (0.07)                  0                                              1 (0.61)
  **03:01**          626 (22.18)               15 (8.72)[a](#tbl8fna){ref-type="table-fn"}    30 (18.29)
  **03:02**          297 (10.52)               27 (15.70)                                     51 (31.10)[b](#tbl8fnb){ref-type="table-fn"}
  **03:03**          75 (2.66)                 4 (2.33)                                       1 (0.61)
  **03:04**          3 (0.11)                  0                                              0
  **03:05**          1 (0.04)                  0                                              1 (0.61)
  **03:19**          13 (0.46)                 0                                              2 (1.22)
  **04**             0                         1 (0.58)                                       1 (0.61)
  **04:01**          3 (0.11)                  0                                              0
  **04:02**          170 (6.02)                12 (6.98)                                      9 (5.49)
  **05**             0                         7 (4.07)                                       22 (13.41)
  **05:01**          328 (11.62)               59 (34.30)[c](#tbl8fnc){ref-type="table-fn"}   10 (6.10)
  **05:02**          91 (3.22)                 11 (6.40)                                      3 (1.83)
  **05:03**          69 (2.45)                 1 (0.58)                                       11 (6.71)[d](#tbl8fnd){ref-type="table-fn"}
  **05:05**          1 (0.04)                  0                                              0
  **06**             8 (0.28)                  0                                              0
  **06:01**          19 (0.67)                 0                                              3 (1.83)
  **06:02**          263 (9.32)                16 (9.30)                                      3 (1.83)[e](#tbl8fne){ref-type="table-fn"}
  **06:03**          226 (8.01)                3 (1.74)[f](#tbl8fnf){ref-type="table-fn"}     4 (2.44)
  **06:04**          99 (3.51)                 1 (0.58)                                       3 (1.83)
  **06:09**          29 (1.03)                 0                                              0
  **06:11**          5 (0.18)                  0                                              0
  **16:02**          1 (0.04)                  0                                              0

RR=relative risk, CI=confidence interval.

*P*=2×10^−4^, RR=0.39, 95% CI=0.24--0.64.

*P*=2.5×10^−10^, RR=2.95, 95% CI=2.3--3.80.

*P*=2.5×10^−10^, RR=2.95, 95% CI=2.34--3.71.

*P*=0.02, RR=2.74, 95% CI=1.49--5.08.

*P*=7.5×10^−3^, RR=0.19, 95% CI=0.06--0.60.

*P*=0.02, RR=0.22, 95% CI=0.07--0.67.
